Accelerating Evidence-based Action for Every Family Everywhere LAUNCH: WHO’s Full Value of Vaccines Assessment Report
Wednesday 3rd November from 1.30 pm (free to attend virtually online), Time Zone London, UK (GMT)
Hosted by The London School of Hygiene & Tropical Medicine
Worldwide over 20 million pregnant women are estimated to be affected by Group B Streptococcal infection. To date, most focus has been on infections in children, yet there are many additional consequences for women themselves, including stillbirths, preterm birth and long-term impacts for affected survivors. The WHO-led Value Case Proposition includes years of work by many teams from all over the world on new data, analysis regarding long-term health and economic consequences of GBS disease, and estimated costs/benefits of vaccination or other prevention approaches. The report findings will be relevant for families, policymakers, clinicians, scientists, & industry. There will be a particular spotlight on meningitis and this Report is linked to the WHO Global Roadmap to Defeat Meningitis by 2030.
This event will be live-streamed here: https://www.who.int/news-room/events/detail/2021/11/03/default-calendar/issad-global-conference-on-group-b-strep
You can also join the webinar here: https://lshtm.zoom.us/j/96388532300
There is no password to join the link above on Wednesday 3rd November at 13.30 pm (GMT). (You will not be able to join the webinar link before the 3rd of November).
Full agenda below.
Plenary 1 – Launch of GBS Value Case report results with linked papersWelcome with Dr Kim Eva Dickson (UNICEF) - MC
Launch of WHO Full Value of Vaccines Assessment ReportDr Tedros Adhanom Ghebreyesus - Director-General of the World Health Organization
The global value of GBS vaccines Time to actDr Philipp Lambach, WHO
GBS burden through lifecycle & around the world (talk)With Prof Joy Lawn, Director of the MARCH Centre, London School of Hygiene and Tropical Medicine, Film - Every Family: Acting on Group B Strep
The Economic Case for a GBS Vaccine (talk)Prof Mark Jit, London School of Hygiene and Tropical Medicine
Q&A from audienceDr Philipp Lambach (WHO), Prof Joy Lawn, (LSHTM), Prof Mark Jit (LSHTM)
PLENARY 2 – Implications of the evidenceWelcome back with Dr Kim Eva Dickson (UNICEF)
Keynote: Vaccines & equity: the value case for GBS maternal vaccinesDr Kate O’Brien, Director of the Department of Immunization, Vaccines and Biological (WHO)
Panel DiscussionDr Marta Tufet, Head of Policy (GAVI), Dr Martina Baye (Government of Cameroon), Dr Annaliese Anderson (Pfizer), Dr Anisur Rahman Siddique (UNICEF), Dr Ajoke Sobanjo – Ter Meulen (Bill & Melinda Gates Foundation)
Closing comments from launch convenorsDr Marie-Pierre Preziosi (WHO), Vinny Smith (CEO of Meningitis Research Foundation), Prof Beate Kampmann, Director of The Vaccine Centre at the London School of Hygiene and Tropical Medicine
Close by ChairImplications for action from launch - call to action - where to get more info...
Close of Day